Literature DB >> 21161286

A case of systemic amyloidosis associated with cyclic neutropenia.

HyunKyung Lee1, Kyoung Hee Han, Yun Hye Jung, Hee Gyung Kang, Kyung Chul Moon, Il Soo Ha, Yong Choi, Hae Il Cheong.   

Abstract

Reactive AA amyloidosis is caused by the accumulation of the acute phase reactant, serum amyloid A (SAA), as a complication of chronic inflammatory conditions. Cyclic neutropenia is a rare hereditary disorder characterized by repeated episodes of neutropenia at regular intervals, with or without concurrent infection, and is known to be a rare cause of AA amyloidosis. Here, we report a case of a patient who developed systemic AA amyloidosis following a prolonged course of undiagnosed cyclic neutropenia. The patient had a history of recurrent infections since infancy and developed goiter, proteinuria, and azotemia at age 14 years. Her SAA level was markedly increased (601.8 μg/mL, normal range <8 μg/mL), and a thyroid and kidney biopsy revealed typical lesions of AA amyloidosis. Amyloid deposits were also detected in the myocardium, colon, and gallbladder. She had repeated episodes of neutropenia regularly at 3-week intervals and a pathogenic mutation in the ELA2 gene. After 10 months of treatment with recombinant human granulocyte colony-stimulating factor, her SAA level normalized (<2.5 μg/mL), but her renal function did not recover. This case clearly shows that cyclic neutropenia can be complicated by AA amyloidosis unless it is detected early and treated adequately.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21161286     DOI: 10.1007/s00467-010-1715-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

Review 1.  Cyclic neutropenia complicated by renal AA amyloidosis.

Authors:  A Metin; F Ersoy; K Tinaztepe; N Beşbaş; I Tezcan; O Sanal
Journal:  Turk J Pediatr       Date:  2000 Jan-Mar       Impact factor: 0.552

2.  Treatment of cyclic neutropenia with granulocyte colony-stimulating factor.

Authors:  W P Hammond; T H Price; L M Souza; D C Dale
Journal:  N Engl J Med       Date:  1989-05-18       Impact factor: 91.245

3.  Amyloidosis associated with cyclic neutropenia in the dog.

Authors:  N F Cheville
Journal:  Blood       Date:  1968-01       Impact factor: 22.113

4.  Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis.

Authors:  M Horwitz; K F Benson; R E Person; A G Aprikyan; D C Dale
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

5.  Cyclic neutropenia. A tale of two brothers and their family.

Authors:  R D Lange; C G Crowder; P Cruz; S W Hawkinson; C B Lozzio; E Machado; P Painter; W Terry; J B Jones
Journal:  Am J Pediatr Hematol Oncol       Date:  1981

6.  Cyclic neutropenia in grey collie dogs.

Authors:  J E Lund; G A Padgett; R L Ott
Journal:  Blood       Date:  1967-04       Impact factor: 22.113

Review 7.  Cyclic neutropenia.

Authors:  David C Dale; Audrey Anna Bolyard; Andrew Aprikyan
Journal:  Semin Hematol       Date:  2002-04       Impact factor: 3.851

8.  The cyclic hematopoietic dog: a model for spontaneous secondary amyloidosis. A morphologic study.

Authors:  E A Machado; R S Gregory; J B Jones; R D Lange
Journal:  Am J Pathol       Date:  1978-07       Impact factor: 4.307

Review 9.  Clinical and therapeutic aspects of AA amyloidosis.

Authors:  B P Hazenberg; M H van Rijswijk
Journal:  Baillieres Clin Rheumatol       Date:  1994-08

10.  A case of generalized amyloidosis associated with cyclic neutropenia.

Authors:  T Shiomura; Y Ishida; N Matsumoto; K Sasaki; T Ishihara; S Miwa
Journal:  Blood       Date:  1979-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.